APRISO IS A ONCE-DAILY 5-ASA PROVEN TO MAINTAIN ULCERATIVE COLITIS (UC) REMISSION IN ADULTS FOR UP TO 6 MONTHS1
APRISO features INTELLICOR® delayed- and extended-release delivery designed to provide locally acting coverage in the colon.1
The recommended daily dosage is 4 APRISO 0.375-g capsules taken once daily (1.5 g/day) in the morning with or without food to help your patients maintain remission.1
- In clinical studies, ~7 of 10 patients in the intent-to-treat population maintained remission for up to 6 months—compared with ~5.5 of 10 patients on placebo
- Caution should be exercised when administering APRISO to patients with liver disease, known renal dysfunction or a history of renal disease
- The most common adverse events were headache, diarrhea, upper abdominal pain, nausea, nasopharyngitis, influenza and influenza‐like illness, and sinusitis
Help Your Patients Make the Move
Maintaining remission in UC can be a real challenge. Salix offers a range of resources including the APRISO Instant Savings Card, APRISO Patient Brochure, Doctor Discussion Guide, UC Symptom Tracker, UC For Dummies®, and the UCan Patient Support Program to help patients who are prescribed APRISO.